STAGE IIIA NON-SMALL CELL LUNG CANCER
Clinical trials for STAGE IIIA NON-SMALL CELL LUNG CANCER explained in plain language.
Never miss a new study
Get alerted when new STAGE IIIA NON-SMALL CELL LUNG CANCER trials appear
Sign up with your email to follow new studies for STAGE IIIA NON-SMALL CELL LUNG CANCER, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
Genom att skicka in godkänner du våra Användarvillkor
-
New combo therapy for advanced lung cancer shows promise in early trial
Disease control CompletedThis study tested a new treatment approach for people with advanced non-small cell lung cancer that cannot be removed with surgery. The treatment combined MRI-guided radiation, chemotherapy, and an immunotherapy drug called durvalumab. The goal was to see if this approach is safe…
Matched conditions: STAGE IIIA NON-SMALL CELL LUNG CANCER
Phase: PHASE2 • Sponsor: Washington University School of Medicine • Aim: Disease control
Last updated May 26, 2026 07:03 UTC
-
New drug cocktail shows promise for tough lung cancers
Disease control CompletedThis study tested two drugs, auranofin and sirolimus, together in 29 people with advanced lung cancer that had stopped responding to standard treatments. The goal was to find the best dose and see if the combination could slow or stop cancer growth. The trial focused on safety an…
Matched conditions: STAGE IIIA NON-SMALL CELL LUNG CANCER
Phase: PHASE1, PHASE2 • Sponsor: Mayo Clinic • Aim: Disease control
Last updated May 26, 2026 07:01 UTC
-
Experimental combo shows promise in Tough-to-Treat lung cancer
Disease control CompletedThis study tested a new combination treatment for people with advanced non-small cell lung cancer that had already been treated. The treatment combined a cancer vaccine (TG4010) with an immunotherapy drug (nivolumab) to help the immune system fight the cancer. The trial included …
Matched conditions: STAGE IIIA NON-SMALL CELL LUNG CANCER
Phase: PHASE2 • Sponsor: Megan Daly, MD • Aim: Disease control
Last updated May 26, 2026 06:58 UTC
-
Promising combo targets tough cancers in early trial
Disease control CompletedThis study tested a combination of two drugs—sEphB4-HSA and pembrolizumab—in 42 people with advanced non-small cell lung cancer or head & neck cancer that had spread or returned. The goal was to see if the combo could shrink tumors better than standard treatments. Participants ha…
Matched conditions: STAGE IIIA NON-SMALL CELL LUNG CANCER
Phase: PHASE2 • Sponsor: University of Southern California • Aim: Disease control
Last updated May 26, 2026 06:46 UTC
-
Triple therapy for lung cancer shows promise in early safety trial
Disease control CompletedThis early-stage trial tested adding the immunotherapy drug pembrolizumab to standard chemotherapy and radiation for people with stage II to IIIB non-small cell lung cancer. The main goal was to find the safest dose and identify side effects, especially severe lung inflammation. …
Matched conditions: STAGE IIIA NON-SMALL CELL LUNG CANCER
Phase: PHASE1 • Sponsor: Rutgers, The State University of New Jersey • Aim: Disease control
Last updated May 26, 2026 06:44 UTC
-
Could a diabetes drug boost lung cancer treatment?
Disease control CompletedThis study looked at whether adding metformin (a common diabetes medicine) to standard chemotherapy and radiation helps people with stage III non-small cell lung cancer live longer without their cancer growing. About 170 adults with this type of lung cancer took part. The goal wa…
Matched conditions: STAGE IIIA NON-SMALL CELL LUNG CANCER
Phase: PHASE2 • Sponsor: NRG Oncology • Aim: Disease control
Last updated May 20, 2026 11:56 UTC